BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20332657)

  • 1. Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancers.
    Smith IM; Mithani SK; Mydlarz WK; Chang SS; Califano JA
    ORL J Otorhinolaryngol Relat Spec; 2010; 72(1):44-50. PubMed ID: 20332657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
    Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
    Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus.
    Alter BP; Giri N; Savage SA; Quint WG; de Koning MN; Schiffman M
    Int J Cancer; 2013 Sep; 133(6):1513-5. PubMed ID: 23558727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
    Wreesmann VB; Estilo C; Eisele DW; Singh B; Wang SJ
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):218-25. PubMed ID: 17409780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
    Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
    Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
    Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
    Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma.
    Szaumkessel M; Richter J; Giefing M; Jarmuz M; Kiwerska K; Tönnies H; Grenman R; Heidemann S; Szyfter K; Siebert R
    Int J Oncol; 2011 Aug; 39(2):505-14. PubMed ID: 21567085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational and Functional Analysis of
    Glaas MF; Wiek C; Wolter LM; Roellecke K; Balz V; Okpanyi V; Wagenmann M; Hoffmann TK; Grässlin R; Plettenberg C; Schipper J; Hanenberg H; Scheckenbach K
    Anticancer Res; 2018 Mar; 38(3):1317-1325. PubMed ID: 29491055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells are enriched in Fanconi anemia head and neck squamous cell carcinomas.
    Wu J; Mu Q; Thiviyanathan V; Annapragada A; Vigneswaran N
    Int J Oncol; 2014 Dec; 45(6):2365-72. PubMed ID: 25340704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
    Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
    Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
    Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.
    Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM
    Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of guanine nucleotide-binding protein γ-7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling.
    Demokan S; Chuang AY; Chang X; Khan T; Smith IM; Pattani KM; Dasgupta S; Begum S; Khan Z; Liegeois NJ; Westra WH; Sidransky D; Koch W; Califano JA
    Int J Oncol; 2013 Apr; 42(4):1427-36. PubMed ID: 23403885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma.
    Zuo C; Zhang H; Spencer HJ; Vural E; Suen JY; Schichman SA; Smoller BR; Kokoska MS; Fan CY
    Otolaryngol Head Neck Surg; 2009 Oct; 141(4):484-90. PubMed ID: 19786217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation and inactivation of hMLH1, a DNA mismatch repair gene, in head and neck squamous cell carcinoma.
    Liu K; Zuo C; Luo QK; Suen JY; Hanna E; Fan CY
    Diagn Mol Pathol; 2003 Mar; 12(1):50-6. PubMed ID: 12605036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.
    Guerrero-Preston R; Michailidi C; Marchionni L; Pickering CR; Frederick MJ; Myers JN; Yegnasubramanian S; Hadar T; Noordhuis MG; Zizkova V; Fertig E; Agrawal N; Westra W; Koch W; Califano J; Velculescu VE; Sidransky D
    Epigenetics; 2014 Jul; 9(7):1031-46. PubMed ID: 24786473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of galanin receptor 1 in head and neck cancer.
    Misawa K; Ueda Y; Kanazawa T; Misawa Y; Jang I; Brenner JC; Ogawa T; Takebayashi S; Grenman RA; Herman JG; Mineta H; Carey TE
    Clin Cancer Res; 2008 Dec; 14(23):7604-13. PubMed ID: 19047085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.